InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by MANUSO JAMES S J, Director. Officer active across 1 companies, notably Ocuphire Pharma, Inc.. In total, 3 filings have been recorded. Total volume traded: €22k. The latest transaction was disclosed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€9,4055,000 shares@ €1.881143.2% of flow
Common Stock
SEC:0001140361-22-020364:0·
Ideal exit: 14 Feb 2023 (T+270)
€6,1832,000 shares@ €3.0915100.0% of flow
Common Stock
SEC:0001140361-21-038872·
Ideal exit: 15 Aug 2022 (T+270)
€6,1832,000 shares@ €3.091528.4% of flow
Common Stock
SEC:0001140361-21-038872:0·
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About MANUSO JAMES S J
James S J Manuso is a Director at Ocuphire Pharma, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. James is involved in key decisions that influence the future of Ocuphire Pharma.
